Emmanuelle Charpentier

Emmanuelle Charpentier

French microbiologist, biochemist and Nobel laureate (born 1968)

Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French academic, microbiologist, geneticist, and biochemist. She has served as a director at the Max Planck Institute for Infection Biology in Berlin since 2015.2

From Wikipedia’s article on Emmanuelle Charpentier (this version), CC BY-SA 4.0.

Born Dec 11, 1968.1

About

Three years later, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR). This was the first science Nobel Prize ever won exclusively by two women.

From Wikipedia’s article on Emmanuelle Charpentier, shared under CC BY-SA 4.0.2

Companies

Early life and education

  • 1995Pasteur Institute doctorate in France; microbiology3 4
  • 1995Pierre and Marie Curie University doctorate in France; microbiology3 4

Charpentier's paternal grandfather, surnamed Sinanian, was an Armenian who escaped to France during the Armenian Genocide and met his wife in Marseille. Charpentier was born in 1968 in Juvisy-sur-Orge in France and studied biochemistry, microbiology, and genetics at the Pierre and Marie Curie University (which became the Faculty of Science of Sorbonne University) in Paris. She was a graduate student at the Institut Pasteur from 1992 to 1995 and was awarded a research doctorate. Charpentier's PhD work investigated molecular mechanisms involved in antibiotic resistance.

From Wikipedia’s article on Emmanuelle Charpentier (this version), CC BY-SA 4.0.

Career

Occupation: biochemist, immunologist, microbiologist, geneticist, scientist, university teacher, director.9

  • Since 2018Worked at Max Planck Unit for the Science of Pathogens5 7
  • Date not recordedWorked at Umeå University5
  • Date not recordedWorked at University of Vienna5
  • Date not recordedWorked at Hannover Medical School5
  • Date not recordedDirector, Max Planck Institute for Infection Biology5 6
  • Date not recordedFounded CRISPR Therapeutics8

Charpentier worked as a university teaching assistant at Pierre and Marie Curie University from 1993 to 1995 and as a postdoctoral fellow at the Institut Pasteur from 1995 to 1996. She moved to the US and worked as a postdoctoral fellow at Rockefeller University in New York from 1996 to 1997. During this time, Charpentier worked in the lab of microbiologist Elaine Tuomanen. Tuomanen's lab investigated how the pathogen Streptococcus pneumoniae utilizes mobile genetic elements to alter its genome. Charpentier also helped to demonstrate how S. pneumoniae develops vancomycin resistance.

Charpentier was an assistant research scientist at the New York University Medical Center from 1997 to 1999. She worked in the lab of Pamela Cowin, a skin-cell biologist interested in mammalian gene manipulation. Charpentier published a paper exploring the regulation of hair growth in mice. She held the position of Research Associate at the St. Jude Children's Research Hospital and at the Skirball Institute of Biomolecular Medicine in New York from 1999 to 2002.

After five years in the United States, Charpentier returned to Europe and became the lab head and a guest professor at the Institute of Microbiology and Genetics, University of Vienna, from 2002 to 2004. In 2004, Charpentier published her discovery of an RNA molecule involved in the regulation of virulence-factor synthesis in Streptococcus pyogenes. From 2004 to 2006, she was lab head and an assistant professor at the Department of Microbiology and Immunobiology. In 2006, she became a privatdozentin (Microbiology) and received her habilitation at the Centre of Molecular Biology. From 2006 to 2009 she worked as lab head and associate professor at the Max F. Perutz Laboratories.

Charpentier moved to Sweden and became lab head and associate professor at the Laboratory for Molecular Infection Medicine Sweden (MIMS), at Umeå University. She held the position of group leader from 2008 to 2013 and was visiting professor from 2014 to 2017. She moved to Germany to act as department head and W3 Professor at the Helmholtz Centre for Infection Research in Braunschweig and the Hannover Medical School from 2013 until 2015. In 2014, she became an Alexander von Humboldt Professor.

In 2015, Charpentier accepted an offer from the German Max Planck Society to become a scientific member of the society and a director at the Max Planck Institute for Infection Biology in Berlin. Since 2016, she has been an Honorary Professor at Humboldt University in Berlin. Charpentier retained her position as visiting professor at Umeå University until the end of 2017 when a new donation from the Kempe Foundations and the Knut and Alice Wallenberg Foundation allowed her to offer more young researchers positions within research groups of the MIMS Laboratory. In 2018, she became the founding and acting director of the Max Planck Unit for the Science of Pathogens.

From Wikipedia’s article on Emmanuelle Charpentier (this version), CC BY-SA 4.0.

Personal life

  • BornDec 11, 1968, Juvisy-sur-Orge10
  • CitizenshipFrance11 12

Awards

  • 2024Foreign Member of the Royal Society13 38
  • 2023Fellow of the American Academy of Arts and Sciences13 36
  • 2023Honorary doctor of the University of Liège13 37
  • 2023National Inventors Hall of Fame13
  • 2020Carl Friedrich Gauss Medal13
  • 2020Commander of the Legion of Honour13 35
  • 2020Nobel Prize in Chemistry13 34
  • 2020Wolf Prize in Medicine13 33
  • 2019Knight Commander's Cross of the Order of Merit of the Federal Republic of Germany13
  • 2019Officer of the National Order of Merit12 13
More awards (44)
  • 2019Scheele Award13 32
  • 2019honorary doctorate from the McGill University13 25
  • 2018Aachener Ingenieurpreis13 31
  • 2018Bijvoet Medal13
  • 2018Harvey Prize13
  • 2018Honorary doctor of the Catholic University of Louvain13 25
  • 2018Kavli Prize in Nanoscience13 30
  • 2018honorary doctor of the University of Manchester13 25
  • 2018honorary doctorate from the University of Cambridge13 25
  • 2017Albany Medical Center Prize13 28
  • 2017Fellow of the AACR Academy13
  • 2017Honorary doctorate of Umeå University13 25
  • 2017Japan Prize13
  • 2017Pour le Mérite for Sciences and Arts order13 29
  • 2016BBVA Foundation Frontiers of Knowledge Award13
  • 2016Canada Gairdner International Award13
  • 2016Gottfried Wilhelm Leibniz Prize13 23
  • 2016John Scott Award13 27
  • 2016L'Oréal-UNESCO Award For Women in Science13
  • 2016Meyenburg Prize13
  • 2016Otto Warburg Medal13 24
  • 2016Paul Ehrlich and Ludwig Darmstaedter Prize13
  • 2016Tang Prize13
  • 2016Warren Alpert Foundation Prize13
  • 2016Wilhelm Exner Medal13 26
  • 2016honorary doctor of the Katholieke Universiteit Leuven13 25
  • 2016honorary doctor of the École polytechnique fédérale de Lausanne13 25
  • 2015Breakthrough Prize in Life Sciences13 18
  • 2015Carus medal13
  • 2015Clarivate Citation Laureates13 21
  • 2015Ernst Jung Prize for Medicine13
  • 2015Gruber Prize in Genetics13
  • 2015Hansen Family Prize13 20
  • 2015Louis-Jeantet Prize for Medicine13 19
  • 2015Massry Prize13
  • 2015Princess of Asturias Award for Technical and Scientific Research13 22
  • 2015Science Award of Lower Saxony13
  • 2014Alexander von Humboldt Professorship13
  • 2014Dr. Paul Janssen Award for Biomedical Research13 16
  • 2014Gabbay Award13 15
  • 2014Göran Gustafsson Prize for molecular biology13
  • 2014honorary doctor of the Hong Kong University of Science and Technology13 17
  • 2011Eric K. Fernströms Svenska Pris13 14
  • Date not recordedEMBO Membership13

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42